USD
EUR
in stock
Prascend (Pergolide) Tablets for Horses, 1-mg
Details
Specifications
Prascend Tablets for Horses is a dopamine receptor agonist that works to help control the signs of PPID —also known as Cushing’s disease— in your horse. PPID is known to affect over 20% of older horses and ponies, generally over the age of 15 years old. Prascend Tablets for Horses can offer you an easy and effective way to help manage symptoms, while also helping to treat the pain and discomfort associated with Cushing’s disease. Unmanaged Cushing’s disease in your horse can impact her overall health and wellbeing, including weight loss and delayed shedding. Horses treated with Prascend Showed improved clinical signs within 3 months with 75% of cases considered treatment successes.\n\n**Proudly sourced directly from the manufacturer or their approved distributor. Guaranteed genuine and backed by the manufacturer.**
| Item Number | 301411 |
|---|---|
| Administration Form | Oral |
| For Use With | Horses |
| Generic Name | pergolide |
| Common Brand Name(s) | Prascend |
| Product Form | Tablet |
| Health Condition | Cushing's Disease, Pituitary Pars Intermedia Dysfunction (PPID) |
| Drug Type | Anti-ulcer |
Uses
For the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease) in horses.
Possible Side Effects
To read more about possible side effects, please review the package insert.
Drug & Food Interactions
Pease consult with your veterinarian for any Food and Drug interaction concerns.
Precautions
Treatment with PRASCEND (pergolide tablets) may cause inappetence. The use of PRASCEND in breeding, pregnant, or lactating horses has not been evaluated. The effects of pergolide mesylate on breeding, pregnant, or lactating horses are not known; however, the pharmacologic action of pergolide mesylate suggests that it may interfere with reproductive functions such as lactation.
Ingredients
Pergolide
Instructions
Recommended Dosage
Administer PRASCEND (pergolide tablets) orally at a starting dose of 2 mcg/kg once daily. Dosage may be adjusted to effect, not to exceed 4 mcg/kg daily. The tablets are scored and the calculated dosage should be provided to the nearest one-half tablet increment. See prescribing information for more dosing instructions.
Storage Instructions
Store at 68F- 77 F (20-25 C). Excursions between 59 F- 86 F (15-30 C) are permitted.
